These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8159909

  • 1. Transfer factor and its signification for practice.
    Mrázová A, Mráz J.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):117-37. PubMed ID: 8159909
    [Abstract] [Full Text] [Related]

  • 2. [Secondary post-traumatic immunodeficiency syndrome in patients in the anesthesiology-resuscitation department. Possibilities of immunomodulation therapy].
    Průcha M, Limberk B.
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):116-20. PubMed ID: 1339602
    [Abstract] [Full Text] [Related]

  • 3. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
    Leser PG, Margarido L, Belda W, Sartori SG, Hares WA, Freire CA, Fleury R, Montenegro MR, Leser W, Naspitz CK.
    Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
    [Abstract] [Full Text] [Related]

  • 4. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].
    Hainaut J, Challan-Belval P, Haguenauer G, Pellegrin J, Allard P, Kermarec J.
    Ann Med Interne (Paris); 1979 Jun; 130(11):517-21. PubMed ID: 317697
    [Abstract] [Full Text] [Related]

  • 5. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A, Thometz D, Garrison O, Hill JM.
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transplenic and transtumoral in vivo immunostimulation: effect on cellular immunity parameters.
    Boura P, Kountouras J, Lygidakis NJ, Safioleas M, Aphinives P.
    Hepatogastroenterology; 1999 May; 46(26):799-803. PubMed ID: 10370616
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Human transfer factor. II. Clinical results with the large pool transfer factor].
    Metzner G, Fricke HJ, Schröder D, Göring HD, Franke W, Karl M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 May; 110(4):526-39. PubMed ID: 6196269
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transfer factor therapy of thoracic sarcoidosis.
    Vezendi S, Schröder I.
    Allergol Immunopathol (Madr); 1989 May; 17(1):35-7. PubMed ID: 2750639
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
    Milosević D, Marinković M, Colović M, Jelić S.
    Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
    [Abstract] [Full Text] [Related]

  • 16. [Transfer factor (TF) - a modulator of immunological activity].
    Grubek-Jaworska H, Komorowska-Rycerz A.
    Postepy Hig Med Dosw; 1981 Jun; 35(6):549-74. PubMed ID: 6752921
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.